Characterization of oligonucleotide transport into living cells.
about
A human gene coding for a membrane-associated nucleic acid-binding protein2'-O-methyl, 2'-O-ethyl oligoribonucleotides and phosphorothioate oligodeoxyribonucleotides as inhibitors of the in vitro U7 snRNP-dependent mRNA processing eventDesign and application of multifunctional DNA nanocarriers for therapeutic deliveryDelivery of oligonucleotides with lipid nanoparticlesGrowth inhibition of head and neck squamous cell carcinoma cells by sgRNA targeting the cyclin D1 mRNA based on TRUE gene silencingInhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidineAntisense knockdown of inducible nitric oxide synthase inhibits the relaxant effect of VIP in isolated smooth muscle cells of the mouse gastric fundusAnti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cellsPhysico-chemical characteristics of lipoplexes influence cell uptake mechanisms and transfection efficacyExtracellularly occurring histone H1 mediates the binding of thyroglobulin to the cell surface of mouse macrophagesPhysical properties of oligonucleotides containing phosphoramidate-modified internucleoside linkages.Towards an improved anti-HIV activity of NRTI via metal-organic frameworks nanoparticles.An antisense oligodeoxynucleotide targeted to chromaffin cell scinderin gene decreased scinderin levels and inhibited depolarization-induced cortical F-actin disassembly and exocytosis.Enhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5' end modified with geraniol.Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation.Receptor-mediated endocytosis of phosphodiester oligonucleotides in the HepG2 cell line: evidence for non-conventional intracellular trafficking.Pharmacology, pharmacokinetics, and metabolism of the DNA-decoy AYX1 for the prevention of acute and chronic post-surgical painIdentification, purification and partial characterisation of an oligonucleotide receptor in membranes of HepG2 cells.CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines.Antisense oligonucleotides as therapeutic agents.mRNA coding for oxytocin is present in axons of the hypothalamo-neurohypophysial tractInterleukin 1 induces beta-endorphin secretion via Fos and Jun in AtT-20 pituitary cellsHypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process.Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotideA short antisense oligonucleotide ameliorates symptoms of severe mouse models of spinal muscular atrophyNewly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors.Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.Mapping targetable sites on human telomerase RNA pseudoknot/template domain using 2'-OMe RNA-interacting polynucleotide (RIPtide) microarrays.Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.Vehicles for oligonucleotide delivery to tumours.Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse.Site specific functionalization of oligonucleotides for attaching two different reporter groups.5'-Cholesteryl-phosphorothioate oligodeoxynucleotides: potent inhibition of methotrexate transport and antagonism of methotrexate toxicity in cells containing the reduced-folate carrier.In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulationIn vivo stability and kinetics of absorption and disposition of 3' phosphopropyl amine oligonucleotidesMechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes.Differential distribution of oligodeoxynucleotides in developing organs with epithelial-mesenchymal interactionsIdentification of the endosomal sorting complex required for transport-I (ESCRT-I) as an important modulator of anti-miR uptake by cancer cells.Vascular complications and gene therapy.
P2860
Q22254772-CE5C71F5-2F49-4808-AD62-66A14764A563Q24631601-2AB07886-9C86-4642-8DF4-5BBDCE678C14Q27007011-7BC2FB13-B095-4AD9-83D3-90DC3C46F822Q27024646-1127BF33-427D-46DB-94A8-65ADD9DB4ECBQ27322637-B559DEF1-1235-4464-B56D-AAF42CA46A6DQ28316278-7055DAA9-87CB-4614-AA6C-1EA8E0683D48Q28359458-C1F77982-5F69-4C45-B5B0-0A7096468221Q28367621-782203ED-BD44-4A5A-86D5-A8EDBA16747FQ28475692-5A9DA572-455E-42DA-AB5C-5B053072ACA7Q28910210-F181D2DA-B8DA-4BDF-A28E-026B238D8B6CQ29041754-8A51951C-FABD-4C09-B5E1-3BB8033CA40CQ30649947-8BDACCB4-306A-4D58-9F1E-4B530B79E435Q31832211-C94188C1-66D3-4074-944D-8DE5AE725F8BQ32035441-519D1F61-099E-4E62-9FE4-9F5679360869Q33338144-D9397B60-4B57-4006-93FB-1154704DE064Q33601089-1949B127-38E3-4E87-A836-C02A5532C527Q33610526-8A7DC876-65EA-4C3A-8A85-70C4D4C30A60Q33614680-11DDF311-6335-4772-A8CC-D9789F0FCFCFQ33647526-3AD91E0C-0E1D-46DD-AF7E-E7AABF4088CEQ33738466-7CD08948-7D6A-47FB-A609-6C37AB88F31EQ33811196-AA5B1B5C-2008-4E91-BA9F-D816E75EF5D3Q33835936-166E64F9-6894-45C3-9C37-67AA09B01A68Q33917462-E9E13A27-B6E8-43F6-8EAC-87B61E60F3ABQ33978043-FC524B04-F3BC-431C-B3D2-60005ADC838CQ34001036-98A4E073-797B-4B9D-AB35-0C3F1C463A27Q34076980-EF79DB80-A8B3-4278-BB05-DB94394F3463Q34204201-A7C87AF4-9AA1-477C-A360-17DCA00CFD6FQ34208911-3A141FC1-1536-4E27-B5D7-C4B6541DE82DQ34299285-F0BEA7E8-5610-4EC7-A5DD-D3D5C63C4168Q34366036-4EF7BD4C-B49C-46C4-90A7-BA388178FF77Q34518719-AE2D11FF-2327-4F2E-B450-CBDEAEC27D64Q34582428-50EEC018-01A3-4469-876E-087D85F30F03Q34634295-6C35E698-5352-4360-9994-0FEA3A53D1BFQ34772710-49364240-03AF-400B-A598-5568D1FA358BQ34859948-88DFA317-48FA-49A4-AD9B-B68DE578DC48Q35012323-457A09E0-0A1B-47CE-8F52-C2D04D047E65Q35041004-600EAF14-84C5-40F4-B395-53C9A1BB05D2Q35042688-B1EF4D1D-8399-4D57-BA38-B36B7417679EQ35098066-51275063-7765-4DC1-B090-5C2FBE0E0887Q35116151-721B0257-2277-4424-9B73-C44281B5C274
P2860
Characterization of oligonucleotide transport into living cells.
description
1989 nî lūn-bûn
@nan
1989 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Characterization of oligonucleotide transport into living cells.
@ast
Characterization of oligonucleotide transport into living cells.
@en
type
label
Characterization of oligonucleotide transport into living cells.
@ast
Characterization of oligonucleotide transport into living cells.
@en
prefLabel
Characterization of oligonucleotide transport into living cells.
@ast
Characterization of oligonucleotide transport into living cells.
@en
P2093
P2860
P356
P1476
Characterization of oligonucleotide transport into living cells.
@en
P2093
Nakanishi M
Neckers LM
Subasinghe C
P2860
P304
P356
10.1073/PNAS.86.10.3474
P407
P577
1989-05-01T00:00:00Z